These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. Tomas C; Elson JL; Strassheim V; Newton JL; Walker M PLoS One; 2020; 15(4):e0231136. PubMed ID: 32275686 [TBL] [Abstract][Full Text] [Related]
5. Phenotypic characteristics of peripheral immune cells of Myalgic encephalomyelitis/chronic fatigue syndrome via transmission electron microscopy: A pilot study. Jahanbani F; Maynard RD; Sing JC; Jahanbani S; Perrino JJ; Spacek DV; Davis RW; Snyder MP PLoS One; 2022; 17(8):e0272703. PubMed ID: 35943990 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). de Vega WC; Herrera S; Vernon SD; McGowan PO BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836 [TBL] [Abstract][Full Text] [Related]
7. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients. Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226 [TBL] [Abstract][Full Text] [Related]
8. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study. Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852 [TBL] [Abstract][Full Text] [Related]
9. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions. Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325 [TBL] [Abstract][Full Text] [Related]
10. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome. Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681 [TBL] [Abstract][Full Text] [Related]
12. A new approach to find biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) by single-cell Raman micro-spectroscopy. Xu J; Potter M; Tomas C; Elson JL; Morten KJ; Poulton J; Wang N; Jin H; Hou Z; Huang WE Analyst; 2019 Jan; 144(3):913-920. PubMed ID: 30207334 [TBL] [Abstract][Full Text] [Related]
13. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients. Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406 [TBL] [Abstract][Full Text] [Related]
14. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients. Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818 [TBL] [Abstract][Full Text] [Related]
15. Could the kynurenine pathway be the key missing piece of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) complex puzzle? Kavyani B; Lidbury BA; Schloeffel R; Fisher PR; Missailidis D; Annesley SJ; Dehhaghi M; Heng B; Guillemin GJ Cell Mol Life Sci; 2022 Jul; 79(8):412. PubMed ID: 35821534 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME/CFS Lymphoblasts. Missailidis D; Sanislav O; Allan CY; Smith PK; Annesley SJ; Fisher PR Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669532 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. Maksoud R; Balinas C; Holden S; Cabanas H; Staines D; Marshall-Gradisnik S J Transl Med; 2021 Feb; 19(1):81. PubMed ID: 33596913 [TBL] [Abstract][Full Text] [Related]
18. Assessing cellular energy dysfunction in CFS/ME using a commercially available laboratory test. Tomas C; Lodge TA; Potter M; Elson JL; Newton JL; Morten KJ Sci Rep; 2019 Aug; 9(1):11464. PubMed ID: 31391529 [TBL] [Abstract][Full Text] [Related]
19. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation. Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879 [TBL] [Abstract][Full Text] [Related]
20. A unique circular RNA expression pattern in the peripheral blood of myalgic encephalomyelitis/chronic fatigue syndrome patients. Cheng Y; Xu SM; Takenaka K; Lindner G; Curry-Hyde A; Janitz M Gene; 2023 Aug; 877():147568. PubMed ID: 37328077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]